Quick answers
- What is Zelvysia?
- Zelvysia is a brand name of Sapropterin dihydrochloride, a prescription medicine. The FDA NDC Directory lists 2 Zelvysia products in 2 strengths and forms.
- Who makes Zelvysia?
- Aucta holds the FDA application for Zelvysia (ANDA218645, approved April 29, 2025).
- Is there a generic or store brand of Zelvysia?
- Yes. The FDA NDC Directory lists 14 other products with the same active ingredients, strength and form as a Zelvysia product, 12 of them generic. Ask your pharmacist whether one is right for you.
- Has Zelvysia been recalled?
- No recall linked to Zelvysia products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Zelvysia is
Each Zelvysia product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Sapropterin dihydrochloride · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| sapropterin dihydrochloride 100 mg powder, for solution (oral) | Zelvysia | 7 products, 7 companies | DailyMed |
| sapropterin dihydrochloride 500 mg powder, for solution (oral) | Zelvysia | 7 products, 7 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Sapropterin dihydrochloride →
FDA approval
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| ANDA218645 | Aucta | April 29, 2025 | 2 |
Companies that list Zelvysia
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Zelvysia products.
- Aucta Pharmaceuticals, Inc.2 products
Recalls
No recall linked to Zelvysia products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.